Vanguard Group Inc Guardant Health, Inc. Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,908,829 shares of GH stock, worth $1.12 Billion. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,908,829
Previous 12,168,020
2.13%
Holding current value
$1.12 Billion
Previous $633 Million
17.5%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding GH
# of Institutions
450Shares Held
130MCall Options Held
2.04MPut Options Held
2.9M-
Black Rock Inc. New York, NY11.2MShares$1.06 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$483 Million0.25% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$464 Million0.05% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$441 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$400 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.62B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...